"Comparison of Intra-articular of 0.2% Ropivacaine vs. 0.75% Ropivacaine in Postoperative of Knee Arthroscopy"

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Knee ArthroscopyAcute Pain
Interventions
DRUG

Ropivacaine 0.75% Injectable Solution

The patients receive 10 ml of intraarticular solution in the knee (at the anatomical point at the level of the upper pole of the ball joint, under the iliotibial band), with different content of ropivacaine 0.75%; the vehicle for application presents the same physical appearance for all patients and is applied by previously standardized treating physicians.

DRUG

Ropivacaine 0.2% Injectable Solution

The patients receive 10 ml of intraarticular solution in the knee (at the anatomical point at the level of the upper pole of the ball joint, under the iliotibial band), with different content of ropivacaine 0.2%; the vehicle for application presents the same physical appearance for all patients and is applied by previously standardized treating physicians.

Trial Locations (1)

05300

American British Cowdray Medical Center, Mexico City

All Listed Sponsors
lead

Paola M Zamora Munoz

OTHER

NCT05807945 - "Comparison of Intra-articular of 0.2% Ropivacaine vs. 0.75% Ropivacaine in Postoperative of Knee Arthroscopy" | Biotech Hunter | Biotech Hunter